M esial temporal lobe epilepsy (TLE) with hippocampal sclerosis (MTLE-HS) is one of the most important surgically amenable epilepsies for medically intractable epilepsy patients. 19, 23 Long-term seizure freedom after temporal lobe resection has been reported to be approximately 65%. 8, 21 Despite significant advances in the surgical procedure and the identification of surgical candidates, approximately 20%-30% of TLE patients continue to have seizures after conventional surgery. Moreover, the probability of seizure freedom 10 years after TLE surgery is reported to range between 40% and 50%. 11 Several explanations have been proffered for these surgical failures, including incomplete resection of epileptogenic structures, generation or reactivation of new epileptogenic foci, a dual pathology, or, possibly, surgical ABBREVIATIONS AED = antiepileptic drug; ATL = anterior temporal lobectomy; ATL-AH = ATL with amygdalohippocampectomy; EEG = electroencephalography; GKRS = Gamma Knife radiosurgery; MTLE = mesial temporal lobe epilepsy; MTLE-HS = MTLE hippocampal sclerosis; TLE = temporal lobe epilepsy.
scarring. 22 Of these causes, incomplete resection of mesial structures is a potent and major cause of surgical failure. Although reoperation may be beneficial in highly selected patients with MTLE-HS, several reports have argued that 52%-63% of patients could be seizure free after reoperation (extension of the cortical resection along the surgical scar) for TLE. 1, 7, 17, 22, 24 Sometimes, additional invasive intracranial electroencephalography (EEG) recordings are needed to reevaluate and confirm the ictal onset zone before reoperation. Therefore, the potential for surgical morbidity and technical difficulties due to adhesion of neurovascular structures to adjacent surgical scar tissue is a concern for neurosurgeons.
As a noninvasive alternative approach to invasive resection, Gamma Knife radiosurgery (GKRS) has a proven efficacy in the treatment of drug-resistant MTLE with a seizure-free rate of 60%-67% at a greater than 24-month follow-up, which is comparable to the rate reported for conventional resective surgery. 2, 3, 14 The advantages of GKRS include a decreased postprocedural morbidity, improved accessibility to deep structures, avoidance of open craniotomy, and reduced hospital stay. 3 Thus, GKRS may be considered an alternative treatment to open cranial reoperation in patients with MTLE-HS who had recurrent or residual seizures after anterior temporal lobectomy (ATL). 25 Because of the relatively small target volume of residual epileptic tissue, radiation can be safer than conventional GKRS as a primary treatment. However, there have been few reports regarding surgical outcomes of GKRS in homogeneous MTLE-HS groups of patients who underwent GKRS due to recurrent or residual seizure after temporal lobectomy.
In the present study, we investigated the characteristics and seizure outcomes following GKRS in patients with MTLE-HS who did not obtain seizure control or had recurrent seizures after previous surgery. We report the long-term follow-up results of GKRS in patients with an incomplete effect of ATL with amygdalohippocampectomy (ATL-AH).
Methods

Patients' Characteristics Prior to GKRS
We reviewed our database in the Epilepsy Center at the Asan Medical Center, Seoul, Korea, from 1995 to 2009. Five hundred thirty-four patients underwent resective surgery for medically intractable partial onset epilepsy at our institution. Of these, 425 patients underwent temporal lobe resections, including 330 patients with the histological diagnosis of MTLE. After ATL-AH in patients with MTLE-HS, 229 patients (76.3%) were seizure free (Engel Class I) at least 2 years before observation point. We included epileptic patients who fulfilled the following 4 criteria: 1) patients with MTLE-HS who underwent ATL-AH; 2) patients with unfavorable outcome (Engel Classes III and IV) after ATL-AH; 3) patients with MTLE-HS who were reevaluated for presurgical workup for residual or recurring seizures after ATL-AH; and 4) patients with MTLE-HS who underwent GKRS for the treatment of the remaining seizures after ATL-AH. We included 12 patients with MTLE-HS who underwent GKRS after ATL. The institu-tional review board of Asan Medical Center approved this retrospective case series.
Demographic Characteristics Before ATL
Before the initial ATL-AH, all patients had drug-resistant epilepsy and received a comprehensive presurgical evaluation that included brain MRI, scalp video-EEG monitoring, and FDG-PET or ictal SPECT. Brain MRI studies with oblique coronal slices showed definite unilateral atrophy and/or increased signal intensities on T2-weighted or FLAIR sequences in the hippocampus ipsilateral to the epileptogenic temporal lobe. Interictal FDG-PET showed decreased metabolism in the temporal area ipsilateral to the hippocampal atrophy. Ictal SPECT showed increased blood perfusion in the temporal area ipsilateral to the hippocampal atrophy. Finally, presurgical workup confirmed the epileptic foci as being unilateral MTLE, consistent with unilateral hippocampal atrophy, in all included patients. The results of the initial preoperative workup, as well as patient characteristics, are summarized in Table 1 .
Surgical Outcomes After ATL and Reevaluation for GKRS
Standard ATL-AH was performed in all patients without further invasive study (left/right 5:7). The histological diagnosis of MTLE-HS was documented in all patients except one because adequate tissue was not obtained (en bloc resection of hippocampal tissue was not available). The pathological findings showed hippocampal sclerosis only (n = 6) and possible dual pathology (hippocampal sclerosis plus other microscopic abnormality: hippocampal sclerosis plus microdysgenesis [n = 2], hippocampal sclerosis plus mild cortical dysplasia [n = 2], and hippocampal sclerosis plus subpial gliosis [n = 1]). Postoperative MRI scans were reviewed by a neuroradiologist (S.J.K.) and confirmed a complete ATL, including resection of mesial structures (amygdala, uncus, head and body of the hippocampus, anterior parahippocampal gyrus, and entorhinal cortex), in 5 of 12 patients. Postoperative MRI showed a remnant hippocampal tail in 5 patients (41.7%), remnant hippocampal tail and amygdala in 1 patient (8.3%), and remnant amygdala in 1 patient (8.3%).
After ATL-AH, 4 of the 12 patients were seizure free 1 year or more, whereas the remaining 8 patients had continuous seizures after ATL-AH. Of the 4 patients who were seizure free for more than 1 year, 2 were seizure free without antiepileptic drugs (AEDs) for 2.8 years and 13.3 years. Nevertheless, frequent seizures recurred after a considerable seizure-free period. All patients in the present study had a poor surgical outcome of Engel Classes III-IV after ATL-AH with a long-term follow-up of 5.9 ± 4.36 years (range 1.3-14.1 years). All patients underwent a presurgical workup to reevaluate them for reoperation, including scalp video-EEG monitoring and brain MRI with oblique coronal images. If the results of video-EEG monitoring were considered congruent to the ipsilateral temporal lobe structure, which had been operated before, the suspected epileptogenic zone was the remnant or adjacent ipsilateral temporal lobe considering reoperation. However, if the EEG results were inconclusive or incongruent corresponding to ipsilateral temporal lobe origin, exploratory craniotomy for invasive monitoring was delib-erated. GKRS was performed for patients who were willing to control the remaining seizures arising from adjacent structures after ATL, but refused to undergo reoperation.
GKRS Protocol
Radiosurgery was performed using a 201-source cobalt-60 model B or C Gamma Knife unit (Elekta Instruments). The stereotactic head frame was applied to the patients after administration of a local anesthetic agent to facilitate pain-free mounting. MRI using a 1-mm axial slice interval with no gap was performed for target localization. The senior author (J.K.L.) and technical assistant (D.H.L.) conducted treatment planning using GammaPlan software (Elekta Instruments). The target of the GKRS included any remnant structures following previously performed ATL-AH, or adjacent regions, such as the posterior fusiform gyrus, posterior parahippocampal gyrus, superior border of the amygdaloid complex, and tail of hippocampus, in cases of complete resection and depending on experimental decision. A representative planning MRI scan is illustrated in Fig. 1 . The mean calculated volume at the 50% isodose target was 4183 ± 1784.7 mm 3 (range 1800-6900 mm 3 ). A marginal dose of 24-25 Gy and mean number of isocenter shots of 7.8 ± 5.7 was administered to the target. The GKRS details are summarized in Table 2 .
Evaluation of Seizure Outcomes After GKRS
Patients were regularly evaluated by investigators (J.K.K., S.A.L., and T.S.K.) at an outpatient clinic every 3 months after GKRS. Patients who had recurrent seizures sometimes visited more frequently. Patients were asked to maintain a diary of dates and details of seizures for presentation at every visit. Pre-and post-GKRS seizure reduction changes were calculated at the individual patient level. As the effectiveness of seizure reduction surgery is evident immediately after lobectomy but is usually delayed after GKRS, the final seizure outcome was assessed during the final 2 years before data analysis, and a minimum of 2 years of stable status was required for the final outcome classification. 3 Post-GKRS seizure outcome was assessed according to Engel's modified classification using all 12 subclasses as follows 3, 5, 6, 20 : Class I, seizure free (Ia, completely seizure free since surgery; Ib, auras only since surgery; Ic, some seizures after surgery but seizure free for ≥ 2 years; and Id, atypical generalized convulsions following AED withdrawal only); Class II, rare seizures, with a maximum of 3 seizures per year (IIa, initially seizure free but currently has rare seizures; IIb, rare seizures since surgery; IIc, rare seizures for ≥ 2 years; and IId, nocturnal seizures only, causing no disability); Class III, worthwhile improvement with a > 90% reduction of seizures (IIIa, worthwhile seizure reduction; and IIIb, prolonged seizure-free intervals for more than half of the follow-up but not < 2 years); and Class IV, no worthwhile improvement (< 90% reduction in seizure frequency; IVa, 60-90% reduction; IVb, no appreciable difference [< 60% reduction]). For categorical comparisons, this classification was divided into favorable (Engel Classes I and II) and unfavorable (Engel Classes III and IV) seizure outcomes. Anticonvulsant medications were modified (continued, increased, reduced, added to, and/or changed) by epileptologists (J.K.K., S.A.L., and T.S.K.). Formal visual field and neurophysiological tests were not performed in this study.
Evaluation of MRI Changes After GKRS
Follow-up MRI was performed in 10 of 12 patients to detect any radiation-induced signal changes at the target structures. Initial brain MRI was performed at 1-2 years in 9 patients after GKRS, and late follow-up MRI was performed at 4-8 years after GKRS in 8 patients. Thus, both initial and late follow-up MRI after GKRS was performed in 7 of 12 patients. All follow-up images were reviewed, and we discussed the post-GKRS signal changes. Signal changes were evaluated on each coronal T2-weighted and axial FLAIR and/or T1-weighted images. Two patients (Cases 1 and 5) underwent neither early nor late follow-up MRI after GKRS.
Statistical Analysis
Demographic data are reported with the use of range and median values for continuous variables. Some numeric variables are provided as the mean ± SD. The correlation between the clinical outcomes after GKRS and MRI changes or radiation parameters was analyzed. Categorical variables were analyzed using the Fisher's exact test, and continuous variables were analyzed with a Mann-Whitney U-test for unpaired variables. A p value < 0.05 was considered statistically significant. All statistical calculations were performed using commercially available software (version 11.0.1, SPSS, Inc.).
Results
Long-Term Clinical Effects
The 12 patients had a mean age of 35.5 ± 9.89 years (range 16-47 years) at the time of the GKRS procedure; there were 8 males. The mean age at the time of ATL was 28.7 ± 10.83 years (range 7-45 years) and the median interval between the initial ATL and the GKRS was 5.9 ± 4.36 years (range 1.3-14.1 years). Five patients were treated on the left side and 7 were treated on the right. All patients were followed up for at least 4 years with a mean duration of 6.18 ± 1.77 years (range 4-8.8 years) after GKRS. Eight of the patients had a longer than 5-year follow-up. The main characteristics of the patients before GKRS are summarized in Table 1 .
At the final 2-year follow-up preceding this analysis, 6 of the 12 patients were considered seizure free (Engel Class Ia, n = 3; Ic, n = 2; Id, n = 1). One patient was in Class II, 2 were in Class III, and the 3 remaining patients were in Class IV. Table 3 and Fig. 2 depict the results obtained during the post-GKRS follow-up. Among 6 seizure-free patients, 3 (Cases 1, 2, and 3) were immediately seizure free after GKRS and never experienced a seizure (Engel Class Ia) during a mean follow-up period of 5.27 years (range 4.6-5.9 years). These patients were classified as the early response group. The patient in Case 6 reported just 1 episode of seizure following abrupt AED withdrawal after alcohol intake with 6.6 years of follow-up after GKRS (Engel Class Id). Two patients (Cases 4 and 5) initially did not show an improvement in seizure frequency for a couple of years after GKRS, but eventually had been seizure free for 4 years at the final outcome assessment (Engel Class Ic), and were classified as the delayed response group. One patient (Case 7) had no seizure reduction for 3 years after GKRS, but had a delayed response and had been seizure free for 2 years at the final follow-up (Engel Class II). Two patients (Cases 8 and 9) had no seizure reduction after GKRS with mean follow-ups of 5.3 and 8.8 years, but recently achieved 1 seizure-free year and were classified as Class IIIb. Thus, 7 patients achieved favorable outcomes (Engel Classes I and II) and the remaining 5 patients showed unfavorable outcomes (Engel Classes III and IV) after GKRS. No patient complained of any aggravation of memory problems, although pre-and post-GKRS neuropsychological test results were unavailable. 
Correlations Between Clinical Seizure Outcome and Radiation Parameters of GKRS
There were no statistically significant differences in the target volume (p = 0.88; 4100 ± 1730 mm 3 vs 4300 ± 2059 mm 3 ) and target points (p = 0.53; 8.0 ± 7.0 vs 7.6 ± 3.8) between patients who showed favorable and unfavorable post-GKRS outcomes ( Table 2 ). In addition, neither target volume (p = 0.82; 4000 ± 1873 mm 3 vs 4367 ± 1849 mm 3 ) nor target points (p = 0.31; 7.5 ± 7.6 vs 8.2 ± 3.7) were different between patients who were immediately seizure free (Class Ia) after GKRS and those who were not.
Appearance of MRI Signal Changes After GKRS
Post-GKRS MRI changes, including focal T2 or FLAIR signal changes, were noted in 4 of 9 patients at the initial follow-up MRI and in all 8 patients at the late follow-up MRI after GKRS. Seven patients were studied with both initial and late follow-up MRI after GKRS. Three of these patients showed post-GKRS changes at initial MRI and subsequent extension of T2-weighted or FLAIR signal changes on late MRI (minimal in 1 patient and remarkable in 2 patients). The remaining 4 patients failed to show any changes on the initial follow-up MRI. However, all of these patients eventually demonstrated post-GKRS changes at the late follow-up MRI. Two patients (Engel Classes Ic and Ia) underwent neither initial nor late MRI. Figure 3 illustrates a typical MRI change after GKRS.
Correlations Between Clinical Seizure Outcome and MRI Changes
Comparisons between the MRI signal change at the initial and follow-up examinations and the clinical outcome were assessed. Post-GKRS outcomes were classified into Engel Classes I and II as the favorable outcome group and Engel Classes III and IV as the unfavorable outcome group. MRI signal changes were assessed by whether MRI signal change after GKRS was present or not on the initial and follow-up scans. Of 4 patients with initial MRI changes, 2 had favorable outcomes and 2 had unfavorable outcomes. Of 5 patients without initial MRI changes, 3 had favorable outcomes. A comparison of post-GKRS out-comes and initial MRI signal changes after GKRS showed no statistical differences (p = 0.64). All 8 patients with late follow-up MRI after GKRS had an MRI signal change. Among them, 4 patients had favorable outcomes but the remaining patients had unfavorable outcomes. Therefore, there were no significant differences in clinical seizure outcome according to the presence of initial or late MRI changes after GKRS.
AEDs After GKRS
All patients at the last follow-up were on a medication regiment. Among the 12 patients, the dose of AEDs was reduced in 6 patients, unchanged in 3 patients, and added to or changed to other AEDs in 3 patients. Five of the 6 patients with Engel Class I outcomes reduced their AED dose and the remaining patients continued the AEDs without change. Three of the 5 patients with unfavorable outcomes after GKRS added to or changed AEDs but the seizure frequency did not improve.
Discussion
The main finding of the present study is that GKRS produces favorable long-term surgical outcomes (Engel Classes I-II) after a mean follow-up of 6 years in 58.3% patients (7 of 12) with MTLE-HS who did not become seizure free or had recurrent seizures (Engel Classes III-IV) after ATL-AH. Reoperation with conventional surgery for the TLE remnant can obtain a seizure outcome rate ranging from 50% to 60%. 1, 7, 17, 22, 24 However, considering the invasiveness and comparable surgical outcomes of the conventional reoperation in those who underwent a failed temporal lobectomy, our present results suggest that GKRS can be considered an alternative treatment to open cranial reoperation in patients with MTLE-HS who had residual or recurrent seizures after ATL-AH.
A noteworthy finding of our study is that immediate and persistent seizure-free statuses (Engel Subclass Ia) were noted in 3 of 12 patients (25%) after GKRS. A high dose of 24 Gy with GKRS achieves early reductions in seizure frequency compared with a low dose of 20 Gy with GKRS, and the clinical effectiveness of the GKRS is delayed to 12 months after GKRS or is often preceded by a period of auras or seizure exacerbation. 2, 3 A recent study of GKRS for recurrent seizures after incomplete ATL reported that significant seizure reduction was found following the first 6-month period after GKRS, although none of the patients became seizure free. 25 In our current study, we used the previously documented effective treatment dose of 24 Gy to the residual tissue of the presumed epileptogenic zone and obtained an immediate response in 3 patients, compared with the relatively delayed effect of radiation in previous studies. We believe that this immediate response to GKRS may be better explained by neuromodulation effects rather than by tissue destruction.
On the other hand, some patients obtained a delayed response in becoming seizure free or only showed a significant seizure reduction in later periods. These patients (Cases 4 and 5) did not show definite signal changes on the initial MR image obtained 1 year after GKRS, unlike the significant signal changes on MRI performed 4 years or more after GKRS, suggesting that structural lesions rather than neuromodulating effects may be more important in seizure control. A previous study supports the belief that radiation-induced MRI changes correlate with the onset of seizure remission. 4 Overall, our present findings indicated that the presence or absence of signal changes on MRI at 1-2 years after GKRS did not correlate with long-term surgical outcome in any group, including the immediate response group. In addition, all patients showed signal changes on MRI performed 4 years or later after GKRS, even though the extent of the signal changes on MRI did not correlate with the clinical outcome.
The mechanisms by which GKRS reduces or eliminates seizures are unclear. Radiosurgery has been shown to obtain seizure remission by significant injury to neuronal tissue in the presumed seizure focus. 4 In contrast, the status of radiation-induced edema did not influence the seizure control of epilepsy associated with vascular malformations. 10 Furthermore, seizure remission after radiosurgery of other epileptic lesions, such as the hypothalamic hamartoma or vascular malformation, does not require radiological changes consistent with radionecrosis. 15, 18 Therefore, tissue destruction is insufficient to explain the clinical effects produced, suggesting function modulation while preserving basic processing. 12, 13 Our present findings also showed that seizure outcome after GKRS is not related to MRI changes, which is consistent with results showing that tissue necrosis is not always required for the antiepileptic effect.
Previous studies have reported that a low radiation dose (< 20 Gy) is often associated with the failure of GKRS to control seizures and a lack of MRI changes 9 and that a higher dose causes greater clinical effects and radiological changes. 4 In our present study, we used the previously documented effective treatment dose of 24 Gy to the residual tissue of the presumed epileptogenic zone, although the target volume was lower than in previous studies (range 1.8-6.9 cm 3 vs 5.5-9 cm 3 ) that used GKRS as an initial surgical treatment in patients with MTLE-HS. 2, 14 Ablation of the entire area of the amygdala and hippocampus requires a large radiation dose and risks local radiation reaction and a greater radiation dose, which can lead to large brain edema and subsequent steroid treatment. Some patients in our current series experienced transient headache, but only one patient had significant brain edema and required steroid treatment. In this regard, the relatively small target volume in our study incorporating residual epileptic tissue may be safer than conventional GKRS as a primary treatment, which requires steroid treatment in up to 60% of patients. 2 In comparison with the approximately 9-to 12-month delay in the appearance of the first neuroradiological changes described in previous reports, 3, 4, 14, 16 more than half of the patients in our present study showed absent or minimal radiological changes at 1 year after GKRS and had particularly delayed GKRS-related MRI changes 4 years later. It may be that the underlying extensive scar change on MRI after ATL could obscure newly developed radiation changes, making them almost indistinguishable from existing scar tissue.
With regard to conventional reoperation surgery, 5 of the 12 patients were not improved or were insufficiently improved after GKRS. In the present study, the epileptogenic zone was reconfirmed as the temporal lobe, ipsilateral to the previous operation site, on presurgical reevaluation that included video-EEG monitoring, MRI, and PET. Studies regarding failed epilepsy cases for MTLE-HS revealed the ipsilateral temporal lobe to be the most common cause of recurrent seizures. The causes of recurrent seizures include the generation of occult or new epileptogenic zones as well as residual epileptogenic tissue. 22 Thus, the reasons for these failures in these patients are not well understood, although the failures are probably related to the extension of the epileptogenic zone beyond the limits of the radiosurgery. 3 Another possible reason for the failure in these patients may be that conventional radiation doses (24 Gy) induce cellular changes, as seen on the MRI scan, but are insufficient to suppress seizures.
The present study has some limitations. First, we did not perform a follow-up visual field test or neuropsychological test. However, no patients in our series complained of memory decline or had noticeable visual field problems. Moreover, none of our patients in the present study had any permanent neurological morbidity or mortality after GKRS. Second, we did not perform follow-up MRI in 3 patients who showed good clinical outcomes (Engel Class I). However, we performed follow-up MRI in most of the patients, which did not affect the analysis of the results.
Conclusions
ATL is the most widely performed standard treatment for MTLE-HS. However, the optimal treatment for failed epileptic surgery in TLE is not currently established, and the question remains as to whether the exact epileptogenic focus related to relapse still matters in spite of extensive reevaluation using integration of multimodal approaches. GKRS at residual tissue after sufficient reinvestigation has no major safety concerns, coupled with the advantage of a relatively small dose of radiation. Comparable seizure relief compared with open cranial reoperation indicates that GKRS can be considered as an alternative noninvasive treatment in patients with MTLE-HS who have residual or recurrent seizures after ATL but refuse reoperation. Our present findings can contribute to decision making when treating patients with failed surgery for MTLE-HS.
